Expression of COX-1 and COX-2 mRNAs in atherosclerotic plaques

Experimental Gerontology

Volumn 37, Issue 7, 2002, Pages 925-929

  McGeer, Patrick L ^a   McGeer, Edith G ^a   Yasojima, Koji ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arteries; C reactive protein; Cyclooxygenase; Cyclooxygenase 2 inhibitors; Inflammation; NSAIDs

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MESSENGER RNA;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CADAVER; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER;

EID: 0036089096     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(02)00028-1     Document Type: Article

References (15)

1. Premortem and postmortem influences on brain RNA
2. NSAIDS and selective COX-2 inhibitors: Competition between gastroprotection and cardioprotection
3. COX-1 and COX-2 tissue expression: Implications and predictions
4. Extensive postmortem stability of RNA from rat and human brain
5. Cardiovascular thrombotic events in controlled clinical trials of rofecoxib
6. Risk of cardiovascular events associated with selective COX-2 inhibitors
7. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
8. Atherosclerosis: An inflammatory disease
9. Messenger RNA degradation in eukarocytes
10. Aspirin for primary prevention of coronary heart disease: Safety and absolute benefits related to coronary risk derived from meta-analysis of randomized trials
11. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions
12. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
13. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs
14. Generation of C-reactive protein and complement components in atherosclerotic plaques
15. High stability of mRNAs postmortem and protocol for their assessment by RT-PCR